1. Home
  2. SYRE vs COHU Comparison

SYRE vs COHU Comparison

Compare SYRE & COHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • COHU
  • Stock Information
  • Founded
  • SYRE 2013
  • COHU 1947
  • Country
  • SYRE United States
  • COHU United States
  • Employees
  • SYRE N/A
  • COHU N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • COHU Electrical Products
  • Sector
  • SYRE Health Care
  • COHU Industrials
  • Exchange
  • SYRE Nasdaq
  • COHU Nasdaq
  • Market Cap
  • SYRE 1.1B
  • COHU 885.9M
  • IPO Year
  • SYRE 2016
  • COHU N/A
  • Fundamental
  • Price
  • SYRE $14.82
  • COHU $21.31
  • Analyst Decision
  • SYRE Strong Buy
  • COHU Buy
  • Analyst Count
  • SYRE 5
  • COHU 6
  • Target Price
  • SYRE $61.25
  • COHU $28.20
  • AVG Volume (30 Days)
  • SYRE 485.5K
  • COHU 368.9K
  • Earning Date
  • SYRE 11-06-2025
  • COHU 10-30-2025
  • Dividend Yield
  • SYRE N/A
  • COHU N/A
  • EPS Growth
  • SYRE N/A
  • COHU N/A
  • EPS
  • SYRE N/A
  • COHU N/A
  • Revenue
  • SYRE N/A
  • COHU $393,941,000.00
  • Revenue This Year
  • SYRE N/A
  • COHU $13.11
  • Revenue Next Year
  • SYRE N/A
  • COHU $11.48
  • P/E Ratio
  • SYRE N/A
  • COHU N/A
  • Revenue Growth
  • SYRE N/A
  • COHU N/A
  • 52 Week Low
  • SYRE $10.91
  • COHU $12.57
  • 52 Week High
  • SYRE $40.26
  • COHU $29.42
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 34.55
  • COHU 60.94
  • Support Level
  • SYRE $15.80
  • COHU $20.64
  • Resistance Level
  • SYRE $17.58
  • COHU $21.49
  • Average True Range (ATR)
  • SYRE 0.74
  • COHU 0.64
  • MACD
  • SYRE -0.24
  • COHU 0.10
  • Stochastic Oscillator
  • SYRE 5.32
  • COHU 87.36

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

Share on Social Networks: